These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

725 related items for PubMed ID: 16029293

  • 21. Second-trimester levels of maternal serum human chorionic gonadotropin and inhibin a as predictors of preeclampsia in the third trimester of pregnancy.
    Lambert-Messerlian GM, Silver HM, Petraglia F, Luisi S, Pezzani I, Maybruck WM, Hogge WA, Hanley-Yanez K, Roberts JM, Neveux LM, Canick JA.
    J Soc Gynecol Investig; 2000; 7(3):170-4. PubMed ID: 10865185
    [Abstract] [Full Text] [Related]

  • 22. Adhesion molecules, activin and inhibin--candidates for the biochemical prediction of hypertensive diseases in pregnancy?
    Hanisch CG, Pfeiffer KA, Schlebusch H, Schmolling J.
    Arch Gynecol Obstet; 2004 Sep; 270(2):110-5. PubMed ID: 12898146
    [Abstract] [Full Text] [Related]

  • 23. Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler.
    Spencer K, Yu CK, Cowans NJ, Otigbah C, Nicolaides KH.
    Prenat Diagn; 2005 Oct; 25(10):949-53. PubMed ID: 16086443
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Activin A and inhibin A as possible endocrine markers for pre-eclampsia.
    Muttukrishna S, Knight PG, Groome NP, Redman CW, Ledger WL.
    Lancet; 1997 May 03; 349(9061):1285-8. PubMed ID: 9142063
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
    Aitken DA, Wallace EM, Crossley JA, Swanston IA, van Pareren Y, van Maarle M, Groome NP, Macri JN, Connor JM.
    N Engl J Med; 1996 May 09; 334(19):1231-6. PubMed ID: 8606718
    [Abstract] [Full Text] [Related]

  • 29. Second trimester serum markers.
    Canick JA, MacRae AR.
    Semin Perinatol; 2005 Aug 09; 29(4):203-8. PubMed ID: 16104669
    [Abstract] [Full Text] [Related]

  • 30. Pre-eclampsia with fetal growth restriction: placental and serum activin A and inhibin A levels.
    Florio P, Ciarmela P, Luisi S, Palumbo MA, Lambert-Messerlian G, Severi FM, Petraglia F.
    Gynecol Endocrinol; 2002 Oct 09; 16(5):365-72. PubMed ID: 12587530
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Quad screen as a predictor of adverse pregnancy outcome.
    Dugoff L, Hobbins JC, Malone FD, Vidaver J, Sullivan L, Canick JA, Lambert-Messerlian GM, Porter TF, Luthy DA, Comstock CH, Saade G, Eddleman K, Merkatz IR, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, D'Alton ME, FASTER Trial Research Consortium.
    Obstet Gynecol; 2005 Aug 09; 106(2):260-7. PubMed ID: 16055573
    [Abstract] [Full Text] [Related]

  • 33. SURUSS in perspective.
    Wald NJ, Rodeck C, Hackshaw AK, Rudnicka A.
    Semin Perinatol; 2005 Aug 09; 29(4):225-35. PubMed ID: 16104673
    [Abstract] [Full Text] [Related]

  • 34. Serum and urine inhibin A but not free activin A are endocrine biomarkers of severe pre-eclampsia.
    Hamar BD, Buhimschi IA, Sfakianaki AK, Pettker CM, Magloire LK, Funai EF, Copel JA, Buhimschi CS.
    Am J Obstet Gynecol; 2006 Dec 09; 195(6):1636-45. PubMed ID: 16959203
    [Abstract] [Full Text] [Related]

  • 35. Mid-trimester uterine artery Doppler screening as a predictor of adverse pregnancy outcome in high-risk women.
    Coleman MA, McCowan LM, North RA.
    Ultrasound Obstet Gynecol; 2000 Jan 09; 15(1):7-12. PubMed ID: 10776006
    [Abstract] [Full Text] [Related]

  • 36. Combining inhibin A with existing second-trimester markers in maternal serum screening for Down's syndrome.
    Cuckle HS, Holding S, Jones R, Groome NP, Wallace EM.
    Prenat Diagn; 1996 Dec 09; 16(12):1095-100. PubMed ID: 8994244
    [Abstract] [Full Text] [Related]

  • 37. Ultrasound detection of placental insufficiency in women with elevated second trimester serum alpha-fetoprotein or human chorionic gonadotropin.
    Toal M, Chaddha V, Windrim R, Kingdom J.
    J Obstet Gynaecol Can; 2008 Mar 09; 30(3):198-206. PubMed ID: 18364097
    [Abstract] [Full Text] [Related]

  • 38. The clinical value of combining maternal serum screening and uterine artery Doppler in prediction of adverse pregnancy outcome.
    Elsandabesee D, Srinivas M, Kodakkattil S.
    J Obstet Gynaecol; 2006 Feb 09; 26(2):115-7. PubMed ID: 16483965
    [Abstract] [Full Text] [Related]

  • 39. First- and second-trimester maternal serum markers of pre-eclampsia in twin pregnancy.
    Svirsky R, Levinsohn-Tavor O, Feldman N, Klog E, Cuckle H, Maymon R.
    Ultrasound Obstet Gynecol; 2016 May 09; 47(5):560-4. PubMed ID: 25865365
    [Abstract] [Full Text] [Related]

  • 40. Uterine artery Doppler velocimetry for the detection of adverse obstetric outcomes in patients with elevated mid-trimester beta-human chorionic gonadotrophin.
    Barkehall-Thomas A, Wilson C, Baker L, ni Bhuinneain M, Wallace EM.
    Acta Obstet Gynecol Scand; 2005 Aug 09; 84(8):743-7. PubMed ID: 16026398
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 37.